Douglas Ingram
2021
Compensation breakdown
| Non-Equity Incentive Plan | $799,227 |
|---|---|
| Salary | $729,675 |
| Other | $17,422 |
| Total | $1,546,324 |
Ingram received $799.2K in non-equity incentive plan, accounting for 52% of the total pay in 2021.
Ingram also received $729.7K in salary and $17.4K in other compensation.
Rankings
In 2021, Douglas Ingram's compensation ranked 7,128th out of 12,415 executives tracked by ExecPay. In other words, Ingram earned more than 42.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,128 out of 12,415 | 43rd |
Division Manufacturing | 3,116 out of 5,501 | 43rd |
Major group Chemicals And Allied Products | 1,374 out of 2,371 | 42nd |
Industry group Drugs | 1,223 out of 2,092 | 42nd |
Industry Pharmaceutical Preparations | 894 out of 1,542 | 42nd |
Pay ratio
| Douglas Ingram's Pay | $1,546,324 |
|---|---|
| Median Employee's Pay | $271,908 |
| Pay Ratio | 6to 1 |
In 2021, the annual total compensation of Douglas Ingram was $1,546,324.
The annual total compensation of the median employee at Sarepta Therapeutics was $271,908.
The ratio of Douglas Ingram's pay to the pay of median employee was therefore 6 to one.
Ingram's colleagues
We found four more compensation records of executives who worked with Douglas Ingram at Sarepta Therapeutics in 2021.
News
April 25, 2022
April 20, 2021
April 21, 2020
April 26, 2019